Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1739644

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1739644

Pain Management Devices Market, by Type, By Application, by End User and by Region

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Pain Management Devices Market is estimated to be valued at USD 4,855.7 Mn in 2025 and is expected to reach USD 7,545.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4,855.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.50% 2032 Value Projection: USD 7,545.7 Mn

Pain management devices include those for cancer pain, nociceptive pain, musculoskeletal pain, and others. There are many different kinds of pain treatment equipment on the market, including ablation devices, transcutaneous electrical nerve stimulators, analgesic infusion pumps, and spinal cord stimulators. These devices work by targeting the source of pain and providing relief through various methods, such as blocking pain signals or releasing medication directly to the affected area. It is important to consult with a healthcare professional to determine the best pain management device for individual needs and conditions. Costly and invasive implantable devices should only be utilized as effective treatments when less aggressive and expensive ones have failed to relieve pain and suffering. When used for the correct reasons by the right people, spinal cord stimulation neuromodulates neuropathic pain signals but not nociceptive pain signals. This results in roughly 60-80% long-term pain alleviation in patients who were tested for efficacy.

Market Dynamics

Devices for neuromodulation are primarily used to treat and reduce the symptoms of neurological illnesses', such as pain, epilepsy, tremor, stroke, etc. Additionally, neuromodulation devices are usedto treat a variety of illnesses linked to aging and neurotic conditions. The prevalence of neurological illnesses is increasing, non-opioid treatments are becoming more popular, and neurostimulation devices provide a variety of advantages, all of which contribute to the market's expansion.

Key features of the study:

  • This report provides an in-depth analysis of the global pain management devices market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, technology advancement, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pain management devices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Stryker Corporation, Pfizer Inc. (Hospira Inc.), Medtronic Plc, Boston Scientific Corporation, Baxter International Inc., Braun Melsungen AG, Abbott Laboratories, Colfax Corporation (Djo Global LLC), Kimberly-Clark Corporation (Baylis Medical), Johnson & Johnson (Codman and Shurtleff, Inc.), Neuspera Medical, ZetrOZ Systems, Therabody, BioElectronics Corporation, Nevro Corp, Stevanato Group S.p.A., Bexson Biomedical, Inc., SPR Therapeutics, Lumaflex, Saluda Medical Pty Limited, DyAnsys Inc., Pacira BioSciences, Inc., InterSystems, Nalu Medical, Inc., and StimaWELL North America Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global pain management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management devices market

Detailed Segmentation:

  • Global Pain Management Devices Market, By Type:
    • Neuromodulation & Neurostimulation Devices
    • Analgesic Infusion Pumps
    • Ablation Devices
  • Global Pain Management Devices Market, By Application:
    • Neuropathic Pain
    • Cancer Pain
    • Facial & Migraine Pain
    • Musculoskeletal Pain
    • Others
  • Global Pain Management Devices Market, By End User:
    • Hospitals
    • Clinics
    • Others
  • Global Pain Management Devices Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Stryker Corporation
    • Pfizer Inc. (Hospira Inc.)
    • Medtronic Plc
    • Boston Scientific Corporation
    • Baxter International Inc.
    • Braun Melsungen AG
    • Abbott Laboratories
    • Colfax Corporation (Djo Global LLC)
    • Kimberly-Clark Corporation (Baylis Medical)
    • Johnson & Johnson (Codman and Shurtleff, Inc.)
    • Neuspera Medical
    • ZetrOZ Systems
    • Therabody Inc.
    • BioElectronics Corporation
    • Nevro Corp
    • Stevanato Group S.p.A.
    • Bexson Biomedical, Inc
    • SPR Therapeutics
    • Lumaflex
    • Saluda Medical Pty Limited
    • DyAnsys Inc
    • Pacira BioSciences, Inc.
    • InterSystems
    • Nalu Medical, Inc.
    • StimaWELL North America Inc.
Product Code: CMI3947

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Technology Advancement
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Pain Management Devices Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Pain Management Devices Market, By Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Neuromodulation & Neurostimulation Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Analgesic Infusion Pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Ablation Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Pain Management Devices Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Neuropathic Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Cancer Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Facial & Migraine Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Musculoskeletal Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Pain Management Devices Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Pain Management Devices Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc. (Hospira Inc.)
  • Medtronic Plc
  • Boston Scientific Corporation
  • Baxter International Inc.
  • B.Braun Melsungen AG
  • Abbott Laboratories
  • Colfax Corporation (Djo Global LLC)
  • Kimberly-Clark Corporation (Baylis Medical)
  • Johnson & Johnson (Codman and Shurtleff, Inc.)
  • Neuspera Medical
  • ZetrOZ Systems
  • Therabody
  • BioElectronics Corporation
  • Nevro Corp
  • Stevanato Group S.p.A.
  • Bexson Biomedical, Inc
  • SPR Therapeutics
  • Lumaflex
  • Saluda Medical Pty Limited
  • DyAnsys Inc
  • Pacira BioSciences, Inc.
  • InterSystems
  • Nalu Medical, Inc.
  • StimaWELL North America Inc.

10. Section

  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!